Search results for "Outbreak"

showing 10 items of 812 documents

Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics

2020

lcsh:R5-9202019-20 coronavirus outbreakOpinionDiabetic kidneyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)renal damageCrashDiseaseGeneral Medicinemedicine.diseaseVirologydiabetic kidney diseasecardiovascular diseaseDiabetes mellitusPandemicmedicineMedicinelcsh:Medicine (General)businessCovid-19chronic kidney diseaseFrontiers in Medicine
researchProduct

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply

2021

lcsh:RC705-779Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19lcsh:Diseases of the respiratory systemAntibodies Monoclonal HumanizedSeverity of Illness Indexchemistry.chemical_compoundTocilizumabchemistrySeverity of illnessHumansMedicinebusinessIntensive care medicineLetter to the Editor
researchProduct

Assessing the case of Dengue in Argentina 2009: discrimination and fear

2010

After almost a decade, the re-appearance of Dengue in Argentina caused panic and fears. Unlike Bolivia, Brazil and Paraguay where policies of preventions have been followed, the future of dengue is uncertain for Argentina; this paper does not have any political affiliation but emphasizes the role that mass media play in the coverage of epidemics. The question as to whether a newspaper or mass media corporation should maintain a minimum of objectivity is too complex to be resolved in this short article. However, we have so far set forth a model which will help other researchers to interpret topics of this nature in the future. In moments of disorder, uncertainty or disaster, societies experi…

media_common.quotation_subjectpanicDengue outbreakCorporationlcsh:Communication. Mass mediaDengue feverNewspapermitigationPoliticsGossipPolitical sciencemedicineObjectivity (science)media_commonMass mediabusiness.industrylcsh:Journalism. The periodical press etc.Communicationlcsh:PN4699-5650medicine.diseaselcsh:P87-96Political economyIdeologybusinessSocial psychologypolitical fields.Brazilian Journalism Research
researchProduct

Norovirus infections and seroprevalence of genotype gii.4-specific antibodies in a spanish population

2015

Genotype II.4 noroviruses (NoVs) are a leading cause of epidemic acute gastroenteritis in children and adults worldwide. The prevalence of different NoV genotypes causing outbreaks and sporadic cases of acute gastroenteritis in the region of Valencia, Spain, during a 4-year period (2008–11) was investigated. NoVs were detected in 42 out of 55 (76.3%) outbreaks and in 26 out of 332 (7.8%) sporadic cases of acute gastroenteritis. Genogroup GII strains were predominant in outbreaks and sporadic cases. Different genotype GII.4 variants were found (Yerseke_2006a, Den Haag_2006b, Apeldoorn_2007, and New Orleans_2009), with the latter variant detected most frequently (35.3%). A recombinant P domai…

medicine.diagnostic_testvirusesvirus diseasesOutbreakBiologymedicine.disease_causeVirologyMicrobiologyTiterfluids and secretionsInfectious DiseasesAntigenVirologyImmunoassayGenotypemedicineNorovirusbiology.proteinSeroprevalenceAntibodyJournal of Medical Virology
researchProduct

Replication and extension of framing effects to compliance with health behaviors during pandemics

2021

Outbreaks of infectious diseases represent a significant challenge for health authorities around the world Public cooperation and compliance with health recommendations constitute critical steps to stop the spread of such diseases But how should these recommendations be framed to achieve the most desirable outcomes? Across two experiments, we show that the classic Asian Disease Problem (Tversy and Kahneman, 1981) is replicable, regardless of disease type (real vs hypothetical) Thus, people are less (vs more) willing to take risks when information is positively (negatively) framed, irrespective of disease type, although they are generally more risk-averse in real pandemics Furthermore, peopl…

medicine.medical_specialty0211 other engineering and technologiesReplication02 engineering and technologyDiseasePsycINFOCompliance (psychology)Swine fluEmotionality021105 building & constructionPandemicmedicineCOVID-19 ; Replication ; Framing ; Swine flu ; Health behavior0501 psychology and cognitive sciencesHealth behaviorSafety Risk Reliability and Quality050107 human factorsPublic health05 social sciencesPublic Health Environmental and Occupational HealthOutbreakFraming effectFramingCovid-19PsychologySafety ResearchSocial psychologySafety Science
researchProduct

Severe asthma at COVID-19 time: what is new on biologic therapies.

2021

medicine.medical_specialty2019-20 coronavirus outbreakAsthma therapyCoronavirus disease 2019 (COVID-19)business.industrySevere asthmaBiologic therapiesMEDLINECOVID-19General MedicineSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseSeverity of Illness IndexAsthmaAsthma; COVID-19; Humans; Severity of Illness Index; Biological TherapyBiological TherapyInternal medicineSeverity of illnessmedicineHumansbusinessAsthmaHumanMinerva medica
researchProduct

COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Ita…

2021

The coronavirus disease 2019 (COVID-19) pandemic has not finished yet, and the most promising option towards its ending is widespread vaccination. Because patients with inflammatory bowel diseases (IBDs), namely Crohn’s disease (CD) and ulcerative colitis (UC), often require immune-modifying treatment, which might increase the risk of opportunistic infection,1 their vaccination history for several infectious diseases is routinely checked, and when inadequate, vaccination is performed at diagnosis or ideally before immune suppressive treatment is started.1 However, IBD patients were not found to be at an increased risk of developing COVID-19 or of experiencing a more severe disease course.2

medicine.medical_specialty2019-20 coronavirus outbreakCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)IBDBrief Report - ClinicalInternal medicinemedicineHumansImmunology and AllergyIn patientAcademicSubjects/MED00260SARS-CoV-2business.industryVaccinationGastroenterologyCOVID-19Inflammatory Bowel DiseasesInflammatory Bowel DiseasesCOVID-19 Vaccines HumanVaccinationIBD Crohn Ulcerative Colitis Vaccination Covid 19 Sars-Cov 2COVID-19; COVID-19 vaccine; IBD; vaccine hesitancyvaccine hesitancybusinessCOVID-19 vaccineInflammatory Bowel Diseases
researchProduct

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficien…

2020

In November 2019, the Italian Society of Endocrinology (SIE) has published a consensus statement on the tailoring of glucocorticoid replacement in adrenal insufciency [1]. A few months later, a novel severe acute respiratory syndrome coronavirus (SARS-CoV2) has been recognized as responsible for COVID-19. The outbreak has now reached pandemic level, with a high global mortality rate [2]. From February on, Italy has experienced an exponential rise in the infected which is estimated to reach 200,000 people, with an overall lethality of approximately 10% [3]. A recent Chinese series of nearly 50,000 patients with confrmed COVID-19 infection found that approximately one-out-of-fve (19%) evolve …

medicine.medical_specialty2019-20 coronavirus outbreakConsensusCoronavirus disease 2019 (COVID-19)Hormone Replacement TherapyEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralConsensuEndocrinologyGlucocorticoidmedicineAdrenal insufficiencyHumansSteroids.Hormone replacement therapyViralIntensive care medicinePandemicsAdrenal insufficiency; COVID-19; Glucocorticoids; SARS-CoV2GlucocorticoidsPandemicbusiness.industryCoronavirus InfectionCOVID-19Pneumoniamedicine.diseaseCOVID-19 Drug TreatmentItalyExpert opinionSARS-CoV2SteroidsbusinessCoronavirus InfectionsCoronavirus InfectionsAdrenal insufficiencyHuman
researchProduct

Providing pediatric well-care and sick visits in the COVID-19 pandemic era: the recommendations of the Italian pediatric society.

2020

AbstractPediatricians have observed a significant decrease in in-person child health visits during the COVID-19 pandemic. In the post lockdown period, the coronavirus trend remains positive in Italy but fears of a second wave have recently grown in Italy due to active hotbeds of contagion. The pandemic may negatively affect the care of pediatric patients and overall children welfare as it may present with severe signs and symptoms or it may complicate. The Italian Pediatric Society recommend to separate well visits from sick ones, to educate families and to promote hygienic strategies to provide an adequate pediatric assistance in case of a second pandemic wave.

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)COVID19Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectPneumonia ViralChild WelfareSigns and symptomsPediatricsChild healthBetacoronavirusPandemicmedicineDisease Transmission InfectiousHumansVisitChildChildrenPandemicsSocieties Medicalmedia_commonMaternal and child healthbusiness.industrySARS-CoV-2lcsh:RJ1-570COVID-19lcsh:PediatricsSettore MED/38ItalyFamily medicinePractice Guidelines as TopicCommentarybusinessCoronavirus InfectionsWelfareItalian journal of pediatrics
researchProduct

COVID-19 and diabetes management: What should be considered?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Clinical effectivenessbusiness.industryEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cardiovascular disease COVID-19 Diabetes DPP4 GLP-1RA Hydroxychloroquine Pioglitazone SGLT-2General Medicinemedicine.diseaseEndocrinologyDiabetes managementDiabetes mellitusInternal MedicinemedicineSodium-Glucose Cotransporter 2 InhibitorIntensive care medicinebusinessPioglitazonemedicine.drugDiabetes research and clinical practice
researchProduct